These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38519642)

  • 1. ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions.
    Durand S; Tang Y; Pommier RM; Benboubker V; Grimont M; Boivin F; Barbollat-Boutrand L; Cumunel E; Dupeuble F; Eberhardt A; Plaschka M; Dalle S; Caramel J
    Oncogene; 2024 May; 43(20):1489-1505. PubMed ID: 38519642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype.
    Sanna A; Phung B; Mitra S; Lauss M; Choi J; Zhang T; Njauw CN; Cordero E; Harbst K; Rosengren F; Cabrita R; Johansson I; Isaksson K; Ingvar C; Carneiro A; Brown K; Tsao H; Andersson M; Pietras K; Jönsson G
    JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36040798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
    Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
    Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX5 is involved in balanced MITF regulation in human melanoma cells.
    Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
    BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSTF2T up-regulates IGHG1 by binding to ZEB1 to promote melanoma cell proliferation, migration, and invasion.
    Li Y; Yun X; Li J; Bai M
    Tissue Cell; 2023 Apr; 81():102029. PubMed ID: 36736099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZEB1 transcription factor promotes immune escape in melanoma.
    Plaschka M; Benboubker V; Grimont M; Berthet J; Tonon L; Lopez J; Le-Bouar M; Balme B; Tondeur G; de la Fouchardière A; Larue L; Puisieux A; Grinberg-Bleyer Y; Bendriss-Vermare N; Dubois B; Caux C; Dalle S; Caramel J
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity.
    Wang J; Farkas C; Benyoucef A; Carmichael C; Haigh K; Wong N; Huylebroeck D; Stemmler MP; Brabletz S; Brabletz T; Nefzger CM; Goossens S; Berx G; Polo JM; Haigh JJ
    PLoS Biol; 2021 Sep; 19(9):e3001394. PubMed ID: 34550965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.
    Anghel SI; Correa-Rocha R; Budinska E; Boligan KF; Abraham S; Colombetti S; Fontao L; Mariotti A; Rimoldi D; Ghanem GE; Fisher DE; Lévy F; Delorenzi M; Piguet V
    Pigment Cell Melanoma Res; 2012 Jul; 25(4):482-7. PubMed ID: 22594792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state.
    Verfaillie A; Imrichova H; Atak ZK; Dewaele M; Rambow F; Hulselmans G; Christiaens V; Svetlichnyy D; Luciani F; Van den Mooter L; Claerhout S; Fiers M; Journe F; Ghanem GE; Herrmann C; Halder G; Marine JC; Aerts S
    Nat Commun; 2015 Apr; 6():6683. PubMed ID: 25865119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression.
    Denecker G; Vandamme N; Akay O; Koludrovic D; Taminau J; Lemeire K; Gheldof A; De Craene B; Van Gele M; Brochez L; Udupi GM; Rafferty M; Balint B; Gallagher WM; Ghanem G; Huylebroeck D; Haigh J; van den Oord J; Larue L; Davidson I; Marine JC; Berx G
    Cell Death Differ; 2014 Aug; 21(8):1250-61. PubMed ID: 24769727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.
    Vlčková K; Vachtenheim J; Réda J; Horák P; Ondrušová L
    J Cell Mol Med; 2018 Apr; 22(4):2240-2251. PubMed ID: 29369499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZEB1 induces ROS generation through directly promoting MCT4 transcription to facilitate breast cancer.
    Han X; Long Y; Duan X; Liu Z; Hu X; Zhou J; Li N; Wang Y; Qin J
    Exp Cell Res; 2022 Mar; 412(2):113044. PubMed ID: 35093305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression.
    Chen Y; Lu X; Montoya-Durango DE; Liu YH; Dean KC; Darling DS; Kaplan HJ; Dean DC; Gao L; Liu Y
    Sci Rep; 2017 Mar; 7(1):45. PubMed ID: 28246385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epigenetic regulation of gene expression in malignant melanoma].
    Laurette P; Koludrovic D; Coassolo S; Davidson I
    Biol Aujourdhui; 2016; 210(4):283-295. PubMed ID: 28327285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
    Tang H; Chen B; Liu P; Xie X; He R; Zhang L; Huang X; Xiao X; Xie X
    Carcinogenesis; 2019 Oct; 40(10):1278-1287. PubMed ID: 30810729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma.
    Siena ÁDD; Plaça JR; Araújo LF; de Barros II; Peronni K; Molfetta G; de Biagi CAO; Espreafico EM; Sousa JF; Silva WA
    Sci Rep; 2019 Aug; 9(1):11350. PubMed ID: 31383874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.
    Eliades P; Abraham BJ; Ji Z; Miller DM; Christensen CL; Kwiatkowski N; Kumar R; Njauw CN; Taylor M; Miao B; Zhang T; Wong KK; Gray NS; Young RA; Tsao H
    J Invest Dermatol; 2018 Jul; 138(7):1582-1590. PubMed ID: 29408204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma.
    Capparelli C; Purwin TJ; Glasheen M; Caksa S; Tiago M; Wilski N; Pomante D; Rosenbaum S; Nguyen MQ; Cai W; Franco-Barraza J; Zheng R; Kumar G; Chervoneva I; Shimada A; Rebecca VW; Snook AE; Hookim K; Xu X; Cukierman E; Herlyn M; Aplin AE
    Nat Commun; 2022 Mar; 13(1):1381. PubMed ID: 35296667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of long and short enhancers in melanoma cell states.
    Mauduit D; Taskiran II; Minnoye L; de Waegeneer M; Christiaens V; Hulselmans G; Demeulemeester J; Wouters J; Aerts S
    Elife; 2021 Dec; 10():. PubMed ID: 34874265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.
    Miskolczi Z; Smith MP; Rowling EJ; Ferguson J; Barriuso J; Wellbrock C
    Oncogene; 2018 Jun; 37(23):3166-3182. PubMed ID: 29545604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.